- Report
- January 2025
- 151 Pages
Global
From €3750EUR$4,150USD£3,206GBP
- Report
- January 2025
- 148 Pages
Global
From €3750EUR$4,150USD£3,206GBP
- Report
- January 2025
- 152 Pages
Global
From €3750EUR$4,150USD£3,206GBP
- Report
- June 2024
- 188 Pages
Global
From €3456EUR$3,825USD£2,955GBP
€4066EUR$4,500USD£3,476GBP
- Report
- April 2025
- 185 Pages
Global
From €3456EUR$3,825USD£2,955GBP
€4066EUR$4,500USD£3,476GBP
- Report
- February 2025
- 187 Pages
Global
From €3456EUR$3,825USD£2,955GBP
€4066EUR$4,500USD£3,476GBP
- Report
- June 2025
- 246 Pages
Global
From €5286EUR$5,850USD£4,519GBP
- Clinical Trials
- December 2024
- 1389 Pages
Global
From €3117EUR$3,450USD£2,665GBP
- Report
- December 2024
- 47 Pages
Global
From €9031EUR$9,995USD£7,721GBP
- Clinical Trials
- June 2024
- 342 Pages
Global
From €3117EUR$3,450USD£2,665GBP
- Clinical Trials
- June 2024
- 250 Pages
Global
From €3117EUR$3,450USD£2,665GBP
- Report
- June 2024
- 219 Pages
Global
From €3253EUR$3,600USD£2,781GBP
- Report
- April 2025
- 81 Pages
Global
From €3500EUR$4,149USD£3,097GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,149USD£3,097GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €3117EUR$3,450USD£2,665GBP
- Report
- August 2024
- 63 Pages
Global
From €3158EUR$3,495USD£2,700GBP
- Report
- May 2025
- 150 Pages
Global
From €3479EUR$3,850USD£2,974GBP
- Report
- January 2025
- 144 Pages
Global
From €2620EUR$2,900USD£2,240GBP
- Report
- March 2025
- 150 Pages
Global
From €2937EUR$3,250USD£2,511GBP
€4382EUR$4,850USD£3,747GBP
- Report
- April 2025
- 150 Pages
Global
From €2937EUR$3,250USD£2,511GBP
€4382EUR$4,850USD£3,747GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more